Back to search

Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.

Data up to Jan 2025

Published1990
Citations28
References43

Total Citations Per Year

Abstract

References (43)

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1986 • 2,918 citations

HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy

1989 • 1,574 citations

Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)

1989 • 1,199 citations

The Accuracy of Reverse Transcriptase from HIV-1

1988 • 982 citations

Fidelity of HIV-1 Reverse Transcriptase

1988 • 919 citations

Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1

1987 • 883 citations

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

1989 • 726 citations

Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

1989 • 662 citations

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

1989 • 628 citations

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

1988 • 540 citations

A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia

1989 • 536 citations

Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase

1981 • 439 citations

A Formalin-Inactivated Whole SIV Vaccine Confers Protection in Macaques

1989 • 419 citations

Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus.

1985 • 337 citations

Vaccine protection against simian immunodeficiency virus infection.

1989 • 324 citations

A molecular clone of HTLV-III with biological activity

1985 • 320 citations

Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity

1988 • 314 citations

Variable and conserved neutralization antigens of human immunodeficiency virus

1986 • 296 citations

Biologically diverse molecular variants within a single HIV-1 isolate

1988 • 285 citations

Induction of HTLV-III/LAV from a Nonvirus-Producing T-Cell Line: Implications for Latency

1986 • 264 citations

Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: Mechanism for persistence in AIDS

1988 • 223 citations

Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.

1984 • 222 citations

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

1989 • 222 citations

Significance of premature stop codons in env of simian immunodeficiency virus

1989 • 220 citations

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene

1988 • 186 citations

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS

1988 • 183 citations

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120.

1988 • 146 citations

Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation.

1975 • 131 citations

Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome.

1988 • 106 citations

Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.

1989 • 106 citations

Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.

1988 • 105 citations

Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.

1989 • 90 citations

Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.

1988 • 70 citations

Depletion of the surface CD4 molecule by the envelope protein of human immunodeficiency virus expressed in a human CD4+ monocytoid cell line

1989 • 60 citations

Studies with inhibitors of oligosaccharide processing indicate a functional role for complex sugars in the transport and proteolysis of friend mink cell focus-inducing murine leukemia virus envelope proteins

1984 • 44 citations

Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.

1987 • 44 citations

Immunoselection of mutants deficient in cell surface glycoproteins encoded by murine erythroleukemia viruses.

1980 • 42 citations

Progress in Vaccines Against AIDS

1989 • 25 citations

An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice

1988 • 23 citations

Obstacles to an AIDS Vaccine

1988 • 13 citations

Monoclonal anti-(T,G)-A—L antibodies: Characterization of fine specificity and idiotype expression

1982 • 11 citations

Variable regions of antibodies to synthetic polypeptides. II. Analysis of variable region genes encoding antibodies specific for (T,G)-A--L.

1986 • 8 citations

Gene regulation: Antics of the elusive trypanosome

1983 • 3 citations

Cited By (0)

No citing papers found in database

Variants selected by treatment of human immunodeficiency virus-infected cells with an… (1990) – The Journal of Experimental Medicine | Metascience Observatory Explorer